Daniel J. Becker is Director of Day One Biopharmaceuticals, Inc.. Currently has a direct ownership of 5,000 shares of DAWN, which is worth approximately $64,500. The most recent transaction as insider was on Jun 01, 2021, when has been sold 5,000 shares (Common Stock) at a price of $16.0 per share, resulting in proceeds of $80,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5K
0% 3M change
0% 12M change
Total Value Held $64,500

Daniel J. Becker Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 01 2021
BUY
Open market or private purchase
$80,000 $16.0 p/Share
5,000 Added 50.0%
5,000 Common Stock

Also insider at

PAND
Pandion Therapeutics, Inc.
SLRN
ACELYRIN, Inc.
DJB

Daniel J. Becker

Director
South San Francisco, CA

Track Institutional and Insider Activities on DAWN

Follow Day One Biopharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DAWN shares.

Notify only if

Insider Trading

Get notified when an Day One Biopharmaceuticals, Inc. insider buys or sells DAWN shares.

Notify only if

News

Receive news related to Day One Biopharmaceuticals, Inc.

Track Activities on DAWN